NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

BioLight Life Sciences Ltd (TA: BOLT)

 
BOLT Technical Analysis
5
As on 11th Jun 2023 BOLT STOCK Price closed @ 625.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1034.89 & Strong Sell for SHORT-TERM with Stoploss of 1162.76 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BOLTSTOCK Price

Open 590.10 Change Price %
High 627.90 1 Day 14.00 2.29
Low 590.00 1 Week 57.20 10.07
Close 625.00 1 Month -75.00 -10.71
Volume 1206 1 Year -627.00 -50.08
52 Week High 1280.00 | 52 Week Low 523.00
 
TA Israel Most Active Stocks
TA125 2008.05 1.06%
BEZQ 472.70 -0.06%
GLEX 8.50 10.39%
CANF 3.20 -3.03%
GIVO-L 47.30 0.00%
LUMI 2815.00 1.26%
ELAL 394.00 3.55%
GNRS 78.90 1.41%
BLRX 37.60 -2.08%
TDGN-L 171.50 17.55%
 
TA Israel Top Gainers Stocks
NXTG 93.80 133.33%
MCTC 95.00 90.00%
EMTC 61.90 34.57%
TDGN-L 171.50 17.55%
NALA 67.00 16.12%
SEFA 67.00 16.12%
SEFA 67.00 16.12%
HROD 51.30 14.00%
NOST 601.90 12.25%
ARDM 37.70 12.20%
 
TA Israel Top Losers Stocks
KMNK 51.00 -23.19%
ULTR 74.10 -16.74%
MEAT 0.77 -9.41%
MEAT 0.77 -9.41%
AVRT 56.90 -8.96%
CHR 68.10 -8.59%
CHR 68.10 -8.59%
CHR 68.10 -8.59%
CHR 68.10 -8.59%
CHR 68.10 -8.59%
 
 
BOLT
Daily Charts
BOLT
Intraday Charts
Whats New @
Bazaartrend
BOLT
Free Analysis
 
BOLT Important Levels Intraday
RESISTANCE698.03
RESISTANCE674.61
RESISTANCE660.13
RESISTANCE645.66
SUPPORT604.34
SUPPORT589.87
SUPPORT575.39
SUPPORT551.97
 
BOLT Forecast May 2024
4th UP Forecast1041.23
3rd UP Forecast907.74
2nd UP Forecast825.23
1st UP Forecast742.72
1st DOWN Forecast507.28
2nd DOWN Forecast424.77
3rd DOWN Forecast342.26
4th DOWN Forecast208.77
 
BOLT Weekly Forecast
4th UP Forecast933.32
3rd UP Forecast834.44
2nd UP Forecast773.32
1st UP Forecast712.20
1st DOWN Forecast537.80
2nd DOWN Forecast476.68
3rd DOWN Forecast415.56
4th DOWN Forecast316.68
 
BOLT Forecast2024
4th UP Forecast2107.63
3rd UP Forecast1632.14
2nd UP Forecast1338.23
1st UP Forecast1044.32
1st DOWN Forecast205.68
2nd DOWN Forecast-88.23
3rd DOWN Forecast-382.14
4th DOWN Forecast-857.63
 
 
BOLT Other Details
Segment EQ
Market Capital 5583224320.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BOLT Address
BOLT
 
BOLT Latest News
 
Your Comments and Response on BioLight Life Sciences Ltd
 
BOLT Business Profile
BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions comprising glaucoma, dry eye syndrome, and age-related macular degeneration. The company's ophthalmic product offering and pipeline of product candidates include IOPtiMate, a laser-based surgical treatment for glaucoma; TeaRx, a point-of-care multi-parameter diagnostic test for dry eye syndrome; Eye-D, a controlled release drug-delivery insert platform; OphRx, a non-invasive topical drug delivery technology; and LipiTear, a micro-emulsion technology for the dry eye treatment, as well as for the treatment of other ocular diseases. It also invests in cancer diagnostics technologies, including proprietary tests that are designated for bladder, cervical, multiple myeloma, and other cancers. The company was formerly known as Bio Light Israeli Life Sciences Investments Ltd. and changed its name to BioLight Life Sciences Ltd. in February 2016. BioLight Life Sciences Ltd. was founded in 2005 and is based in Tel Aviv, Israel. Address: Atidim Park Tel Aviv, Tel Aviv, Israel, 6158101
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service